Specific capture of Pseudomonas aeruginosa for rapid detection of antimicrobial resistance in urinary tract infections

Biosens Bioelectron. 2023 Feb 15:222:114962. doi: 10.1016/j.bios.2022.114962. Epub 2022 Nov 29.

Abstract

Urinary tract infections (UTIs) are among the most predominant microbial diseases, leading to substantial healthcare burdens and threatening human well-being. UTIs can become more critical when caused by Pseudomonas aeruginosa, particularly by antimicrobial-resistant types. Thereby a rapid diagnosis and identification of the antimicrobial-resistant P. aeruginosa can support and guide an efficient medication and an effective treatment toward UTIs. Herein, we designed a platform for prompt purification, and effective identification of P. aeruginosa to combat the notorious P. aeruginosa associated UTIs. A peptide (QRKLAAKLT), specifically binding to P. aeruginosa, was grafted onto PEGylated magnetic nanoclusters and enabled a successful capture and enrichment of P. aeruginosa from artificial human urine. Rapid identification of antimicrobial resistance of the enriched P. aeruginosa can be moreover accomplished within 30 min. These functionalized magnetic nanoclusters demonstrate a prominent diagnostic potential to combat P. aeruginosa associated UTIs, which can be extended to other P. aeruginosa involved infections.

Keywords: Antimicrobial resistance; Magnetic nanoclusters; Pseudomonas aeruginosa; Rapid detection; Specific capture; Urinary tract infections.

MeSH terms

  • Anti-Bacterial Agents / pharmacology
  • Biosensing Techniques*
  • Drug Resistance, Bacterial
  • Humans
  • Microbial Sensitivity Tests
  • Pseudomonas Infections* / diagnosis
  • Pseudomonas Infections* / drug therapy
  • Pseudomonas aeruginosa
  • Urinary Tract Infections* / diagnosis
  • Urinary Tract Infections* / drug therapy

Substances

  • Anti-Bacterial Agents